CatalystWireBeta

Vistry Group

VTY · Main Market · Consumer Products and Services · mcap £696m · 218.8p

Beta Briefing, track record and signals & risks are not ready for Vistry Group yet.

We follow 967 UK small caps and every one of their announcements – often hundreds per company. 71 companies are already wired into a briefing: browse them.

1 investor asked

All announcements Monitoring checked today, 12:35

DateTypeAnnouncementDay
05 Oct 26 Director dealing Director/PDMR Shareholding
01 Oct 26 Director dealing Director/PDMR Shareholding
30 Sep 26 Routine Total Voting Rights
24 Sep 26 Results Half-year Results
H1 26 pre-tax loss of £83.3m adjusted; CEO review announces major restructuring, downsizing and exit from South East.
−3.1%
23 Sep 26 Holding Holding(s) in Company
17 Sep 26 Holding Holding(s) in Company
16 Sep 26 Director dealing Director/PDMR Shareholding
28 Aug 26 Routine Total Voting Rights
26 Aug 26 Holding Holding(s) in Company
25 Aug 26 SAHP Funding Award
Vistry secured £350m direct grant award under government's Social and Affordable Homes Programme to deliver over 3,000 affordable homes.
+16.3%
20 Aug 26 Routine Block Listing Interim Review
17 Aug 26 Director dealing Director/PDMR Shareholding
10 Aug 26 Holding Holding(s) in Company
31 Jul 26 Holding Holding(s) in Company
31 Jul 26 Holding Holding(s) in Company
31 Jul 26 Routine Total Voting Rights
20 Jul 26 Holding Holding(s) in Company
16 Jul 26 Director dealing Director/PDMR Shareholding
15 Jul 26 Holding Holding(s) in Company
15 Jul 26 Holding Holding(s) in Company
15 Jul 26 Director dealing Director/PDMR Shareholding
14 Jul 26 Director dealing Director/PDMR Shareholding
10 Jul 26 Holding Holding(s) in Company
10 Jul 26 Holding Holding(s) in Company
08 Jul 26 Holding Holding(s) in Company
08 Jul 26 Board change Resignation of Chief Financial Officer
CFO Tim Lawlor to step down in October to join private business in different sector.
−7.1%
08 Jul 26 Trading update Trading Update
H1 2026 loss of c.£30m due to cash generation actions; expects materially improved H2 and net cash over £100m by year-end.
−7.1%
07 Jul 26 Holding Holding(s) in Company
03 Jul 26 Holding Holding(s) in Company
01 Jul 26 Holding Holding(s) in Company
30 Jun 26 Routine Total Voting Rights
16 Jun 26 Director dealing Director/PDMR Shareholding
29 May 26 Routine Total Voting Rights
19 May 26 Director dealing Director/PDMR Shareholding
18 May 26 Director dealing Director/PDMR Shareholding
18 May 26 Routine Transaction in Own Shares
13 May 26 Routine Result of AGM
13 May 26 Trading update AGM Trading update
Year-to-date sales up 32% but H1 profit expected significantly lower due to discounting; guidance to middle of analyst range.
−12.3%
11 May 26 Routine Transaction in Own Shares
05 May 26 Holding Holding(s) in Company
05 May 26 Routine Transaction in Own Shares
30 Apr 26 Holding Holding(s) in Company
30 Apr 26 Routine Total Voting Rights
27 Apr 26 Routine Transaction in Own Shares
20 Apr 26 Director dealing Director/PDMR Shareholding
20 Apr 26 Routine Transaction in Own Shares
16 Apr 26 Director dealing Director/PDMR Shareholding
14 Apr 26 Director dealing Director/PDMR Shareholding
13 Apr 26 Director dealing Director/PDMR Shareholding
13 Apr 26 Board change Appointment of Chief Executive Officer
Adam Daniels appointed CEO with immediate effect, succeeding Greg Fitzgerald who steps down.
−3.8%
13 Apr 26 Routine Transaction in Own Shares
07 Apr 26 Routine Transaction in Own Shares
31 Mar 26 Routine Total Voting Rights
30 Mar 26 Routine Transaction in Own Shares
27 Mar 26 Director dealing Director/PDMR Shareholding
27 Mar 26 Director dealing Director/PDMR Shareholding
27 Mar 26 Results Annual Report and Accounts 2025 and Notice of AGM
Annual Report and Accounts 2025 and Notice of 2026 Annual General Meeting
−2.6%
27 Mar 26 Routine Transaction in Own Shares
26 Mar 26 Routine Transaction in Own Shares
25 Mar 26 Routine Transaction in Own Shares
24 Mar 26 Routine Transaction in Own Shares
23 Mar 26 Director dealing Director/PDMR Shareholding
23 Mar 26 Routine Transaction in Own Shares
20 Mar 26 Routine Transaction in Own Shares
19 Mar 26 Routine Transaction in Own Shares
18 Mar 26 Routine Transaction in Own Shares
17 Mar 26 Board change Appointment of Chair
Rob Woodward appointed Non-Executive Chair from May 2026, succeeding Greg Fitzgerald who steps down as Executive Chair.
−1.1%
17 Mar 26 Routine Transaction in Own Shares
16 Mar 26 Director dealing Director/PDMR Shareholding
16 Mar 26 Director dealing Director/PDMR Shareholding
16 Mar 26 Routine Transaction in Own Shares
13 Mar 26 Routine Transaction in Own Shares
12 Mar 26 Holding Holding(s) in Company
12 Mar 26 Director dealing Director/PDMR Shareholding
12 Mar 26 Routine Transaction in Own Shares
11 Mar 26 Routine Transaction in Own Shares
10 Mar 26 Routine Transaction in Own Shares
09 Mar 26 Routine Transaction in Own Shares
06 Mar 26 Routine Transaction in Own Shares
05 Mar 26 Director dealing Director/PDMR Shareholding
05 Mar 26 Director dealing Director/PDMR Shareholding
05 Mar 26 Routine Transaction in Own Shares
04 Mar 26 Board change Executive Chair and CEO to retire
Executive Chair and CEO Greg Fitzgerald to retire, roles to separate, CEO successor search underway.
−25.6%
04 Mar 26 Results Final Results
Full year 2025 results in line with guidance; adjusted profit £268.8m with net debt reduced to £144.2m; 2026 outlook for revenue and volume growth.
−25.6%
04 Mar 26 Routine Transaction in Own Shares
03 Mar 26 Routine Transaction in Own Shares
02 Mar 26 Routine Transaction in Own Shares
27 Feb 26 Routine Total Voting Rights
27 Feb 26 Routine Transaction in Own Shares
26 Feb 26 Routine Transaction in Own Shares
25 Feb 26 Routine Transaction in Own Shares
24 Feb 26 Routine Transaction in Own Shares
23 Feb 26 Routine Transaction in Own Shares
20 Feb 26 Routine Block Listing Interim Review
20 Feb 26 Routine Transaction in Own Shares
19 Feb 26 Routine Transaction in Own Shares
18 Feb 26 Routine Transaction in Own Shares
17 Feb 26 Routine Transaction in Own Shares
16 Feb 26 Director dealing Director/PDMR Shareholding
16 Feb 26 Routine Transaction in Own Shares
13 Feb 26 Routine Transaction in Own Shares
11 Feb 26 Routine Transaction in Own Shares
10 Feb 26 Routine Transaction in Own Shares
09 Feb 26 Routine Transaction in Own Shares
06 Feb 26 Routine Transaction in Own Shares
05 Feb 26 Routine Transaction in Own Shares
04 Feb 26 Routine Transaction in Own Shares
03 Feb 26 Routine Transaction in Own Shares
02 Feb 26 Share buyback - management of the programme
Extended share buyback programme tranche of £15m with Peel Hunt; closed period management confirmed.
+1.7%
02 Feb 26 Routine Transaction in Own Shares
30 Jan 26 Routine Total Voting Rights
30 Jan 26 Routine Transaction in Own Shares
29 Jan 26 Routine Transaction in Own Shares
28 Jan 26 Routine Transaction in Own Shares
27 Jan 26 Routine Transaction in Own Shares
26 Jan 26 Routine Transaction in Own Shares
23 Jan 26 Routine Transaction in Own Shares
22 Jan 26 Routine Transaction in Own Shares
21 Jan 26 Routine Transaction in Own Shares
20 Jan 26 Routine Transaction in Own Shares
19 Jan 26 Routine Transaction in Own Shares
16 Jan 26 Director dealing Director/PDMR Shareholding
16 Jan 26 Routine Transaction in Own Shares
15 Jan 26 Routine Transaction in Own Shares
14 Jan 26 Trading update Trading update
FY25 adjusted profit £270m in line with expectations; revenue flat at £4.2bn with 15,700 completions and 8.4% operating margin.
−9.0%
14 Jan 26 Routine Transaction in Own Shares
13 Jan 26 Routine Transaction in Own Shares
12 Jan 26 Routine Transaction in Own Shares Replacement
12 Jan 26 Routine Transaction in Own Shares
09 Jan 26 Routine Transaction in Own Shares
08 Jan 26 Routine Transaction in Own Shares
07 Jan 26 Routine Transaction in Own Shares
06 Jan 26 Routine Transaction in Own Shares
31 Dec 25 Share buyback - management of the programme
Vistry instructs Peel Hunt to manage share buyback programme during closed period.
+0.5%
31 Dec 25 Routine Total Voting Rights
22 Dec 25 Routine Transaction in Own Shares
19 Dec 25 Director Declaration
In accordance with UK Listing Rule 6.4.9, the Company hereby gives notification that Alice Elizabeth Woodwark, an Independent Non-Executive Director of the Company, has been appointed as a Chief Executive Officer of Vp p
−2.2%
19 Dec 25 Routine Transaction in Own Shares
18 Dec 25 Routine Transaction in Own Shares
17 Dec 25 Routine Transaction in Own Shares
16 Dec 25 Director dealing Director/PDMR Shareholding
16 Dec 25 Routine Transaction in Own Shares
15 Dec 25 Routine Transaction in Own Shares
12 Dec 25 Routine Transaction in Own Shares
11 Dec 25 Routine Transaction in Own Shares
10 Dec 25 Routine Transaction in Own Shares
09 Dec 25 Routine Transaction in Own Shares
08 Dec 25 Routine Transaction in Own Shares
05 Dec 25 Routine Transaction in Own Shares
04 Dec 25 Routine Transaction in Own Shares
03 Dec 25 Director dealing Director/PDMR Shareholding
03 Dec 25 Routine Transaction in Own Shares
02 Dec 25 Routine Transaction in Own Shares
01 Dec 25 Routine Transaction in Own Shares
28 Nov 25 Routine Total Voting Rights
28 Nov 25 Routine Transaction in Own Shares
27 Nov 25 Routine Transaction in Own Shares
26 Nov 25 Routine Transaction in Own Shares
25 Nov 25 Routine Transaction in Own Shares
24 Nov 25 Routine Transaction in Own Shares
21 Nov 25 Routine Transaction in Own Shares
20 Nov 25 Routine Transaction in Own Shares
19 Nov 25 Routine Transaction in Own Shares
18 Nov 25 Routine Transaction in Own Shares
17 Nov 25 Director dealing Director/PDMR Shareholding
17 Nov 25 Routine Transaction in Own Shares
14 Nov 25 Update on AGM Voting
72.97% of shareholders voted to approve Directors' Remuneration Report at AGM on 14 May 2025.
−2.1%
14 Nov 25 Routine Transaction in Own Shares
13 Nov 25 Routine Transaction in Own Shares
12 Nov 25 Routine Transaction in Own Shares
11 Nov 25 Routine Transaction in Own Shares
10 Nov 25 Routine Transaction in Own Shares
07 Nov 25 Routine Transaction in Own Shares
06 Nov 25 Routine Transaction in Own Shares
06 Nov 25 Trading update Trading update
Full year profit growth expectations unchanged; H2 activity building with stronger partner demand and government affordable housing support.
+0.9%
05 Nov 25 Routine Transaction in Own Shares
04 Nov 25 Routine Transaction in Own Shares
03 Nov 25 Routine Transaction in Own Shares
31 Oct 25 Routine Total Voting Rights
31 Oct 25 Routine Transaction in Own Shares
30 Oct 25 Routine Transaction in Own Shares
29 Oct 25 Routine Transaction in Own Shares
28 Oct 25 Routine Transaction in Own Shares
27 Oct 25 Routine Transaction in Own Shares
23 Oct 25 Routine Transaction in Own Shares
22 Oct 25 Routine Transaction in Own Shares
21 Oct 25 Routine Transaction in Own Shares
20 Oct 25 Management of share buyback programme
Extended share buyback programme arrangement with Peel Hunt for next £20m tranche of £130m programme.
−1.1%
20 Oct 25 Routine Transaction in Own Shares
17 Oct 25 Routine Transaction in Own Shares
16 Oct 25 Director dealing Director/PDMR Shareholding
16 Oct 25 Routine Transaction in Own Shares
15 Oct 25 Routine Transaction in Own Shares
14 Oct 25 Director dealing Director/PDMR Shareholding
14 Oct 25 Routine Transaction in Own Shares
13 Oct 25 Routine Transaction in Own Shares
10 Oct 25 Routine Transaction in Own Shares
09 Oct 25 Routine Transaction in Own Shares
08 Oct 25 Routine Transaction in Own Shares
07 Oct 25 Routine Transaction in Own Shares
06 Oct 25 Routine Transaction in Own Shares

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note